News
All NewsAAP NewsPNP Corner
Media
Cure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Diabetes
  • Gastroenterology
    • Formula
    • Nutrition
    • Obesity
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Vaccines
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement

Nina Cosdon

Advertisement

Articles by Nina Cosdon

Which COVID-19 variant caused the most severe disease in children?

ByNina Cosdon
March 7th 2023

Children were hospitalized the most during the Omicron variant, but disease outcomes were the least severe during this variant period.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary Pediatrics

    1

    FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

    2

    Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults

    3

    Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

    4

    Jonathan Flyer, MD, highlights the LEAD initiative to increase pediatric lipid screenings

    5

    Daniele De Luca, MD, discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development

    • About Us
    • Advertise
    • Contact Us
    • Editorial
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us